Bio-Rad
Bio-Rad Laboratories has launched the PTC Harmony Thermal Cycler line, expanding its conventional PCR thermal cycler portfolio for academic and biopharma laboratories.
The new line includes two systems: PTC Harmony 96 and PTC Harmony Deepwell. Bio-Rad designed the thermal cyclers to support PCR applications such as sequencing, cloning, and genotyping, while giving laboratories broader access to optimized workflows.
The PTC Harmony Thermal Cyclers provide the same thermal performance as Bio-Rad’s PTC Tempo line in a streamlined design. The systems include an intuitive user interface, manual lid operation, and flexible connectivity options to simplify protocol management.
Bio-Rad positions the line for scientists seeking faster PCR runs, higher performance, accuracy, and a simplified workflow across a broader range of budgets.
“Tailored to academic and biopharma customers interested in simplified and affordable, high-performance devices, the new line of PTC Harmony Thermal Cyclers delivers the same reliability and high quality that Bio-Rad has been providing for over 35 years,” advises Stephen Kulisch, Vice President of Genomics Product Management at Bio-Rad.
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
“Leveraging our engineering expertise, we continue to develop and manufacture robust and efficient thermal cyclers, demonstrating our ongoing commitment to meeting the needs of all scientists," he adds.
The launch adds to Bio-Rad’s next generation of conventional PCR thermal cyclers. The company describes the PTC Harmony line as part of its reliable thermal cycler portfolio for life science research and clinical diagnostics customers.
Bio-Rad Laboratories, Inc., based in Hercules, California, develops, manufactures, and markets products for the life science research and clinical diagnostics markets. The company operates a global network of research, development, manufacturing, and sales operations, with approximately 7,400 employees and $2.6 billion in revenues in 2025.
This article is based on a press release issued by Bio-Rad.
